Torrent Pharma Launches India’s First Oral Semaglutide at ₹3,999/Month
Torrent Pharma has launched India’s first oral semaglutide, revolutionizing diabetes management with a convenient, affordable option.
semaglutide
Pharmaceutical Stocks Surge as Ozempic Ingredient Patent Expires
Pharmaceutical stocks have surged up to 4% as Ozempic’s key ingredient patent expires, paving the way for generics and transforming obesity treatment.
Natco Introduces Semaglutide at Rs 1,290: A New Era for Diabetes Treatment
Natco Pharma launches semaglutide at Rs 1,290, aiming to make diabetes treatment more accessible and reshape the weight-loss drug market in India.
Semaglutide Patent Expiration Sparks Weight Loss Industry Boom
The expiration of semaglutide’s patent signals a transformative era for weight loss treatments, with generics likely to enhance accessibility.
- 1
- 2